Invitae Corporation

Last price update: 14 Feb 24 22:59 GMT

Price:
$0.02
Open:
$0.02
Previous close:
$0.03
Day's range:
$0.02 - $0.02
Year's range:
$0.01 - $2.34
Net Income per Share:
-5.36
Price-to-Earnings ratio:
-0.00
52-week Price Range:
$0.46
Volume:
$22,459,258.00
Average volume:
$12,701,614.00

Company profile for Invitae Corporation

Invitae Corporation logo

Invitae Corporation is a medical genetics company, based in San Francisco, California, that specializes in integrating genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases. In addition, Invitae Corporation also provides digital health solutions and health data services to its patients, healthcare providers, biopharma companies, and other partners.

The company was founded in 2010 as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation has since grown to become a leading provider of genetic tests and services. The company offers its services to more than 1,000 healthcare providers and biopharma companies, and has expanded its services to more than 25 countries around the world. Invitae Corporation has also invested in research and development initiatives to expand its offerings and develop new technologies to improve patient care.

Invitae Corporation is committed to advancing the field of genetics and making genetic testing more accessible and affordable. To that end, the company has developed a number of initiatives, including a genetic counseling service, a low-cost genetic testing program, and a genetic data sharing platform. Invitae Corporation is also actively working to develop new technologies to improve patient care, such as a cloud-based platform for storing and sharing genetic data.

Invitae Corporation is dedicated to improving healthcare for people around the world. The company has been recognized for its commitment to patient care and has received numerous awards, including the Frost & Sullivan Award for Customer Value Leadership in Genetic Testing, the U.S. News and World Report Best Genetics Lab, and the American College of Medical Genetics and Genomics 2017 Clinical Laboratory Improvement Award.

Stock exchanges:
NYSE
Sector:
Healthcare
Industries:
Ticker:
NVTA
CIK:
0001501134
ISIN:
US46185L1035
Website:
https://www.invitae.com
Phone:
415 374 7782
Origin:
United States
Employees:
1,700